1American Thoracic Society,European Respiratory Society.American Thoracic Society/European Respiratory Society idiopathic pulmonary fibrosis:diagnosis and treatment.International consensus statement.Am J Respir Crit Care Med,2000,161:646-664.
2American Thoracic Society,European Respiratory Society.American Thoracic Society/European Respiratory Society international multidisciplinary Consensus Classification of the idiopatic interstitial pneumonias.Am J Respir Crit Care Med,2002,165:277-304.
3Green FH.Overview of Pulmonary Fibrosis.Chest,2002,122:334S-339S.
4The diagnosis,assessment and treatment of diffuse parenchymal lung disease in adults.Introduction.Thorax,1999,54 Suppl 1:S1-14.
5Awad MR,El-Gamel A,Hasleton P,et al.Genotypic variation in the transforming growth factor-beta1 gene:association with transforming growth factor-beta1 production,fibrotic lung disease,and graft fibrosis after lung transplantation.Transplantation,1998,66:1014-1020.
6Uh ST,Inoue Y,King TE Jr,et al.Morphometric analysis of insulinlike growth factor-Ⅰ localization in lung tissues of patients with idiopathic pulmonary fibrosis.Am J Respir Crit Care Med,1998,158:1626-1635.
7Chen J,Ziboh V,Giri SN.Up-regulation of platelet-activating factor receptors in lung and alveolar macrophages in the bleomycin-hamster model of pulmonary fibrosis.J Pharmacol Exp Ther,1997,280:1219-1227.
8Crystal RG,Bitterman PB,Mossman B,et al.Future research directions in idiopathic pulmonary fibrosis:summary of a National Heart,Lung,and Blood Institute working group.Am J Respir Crit Care Med,2002,166:236-246.
9Hagimoto N,Kuwano K,Inoshima I,et al.TGF-beta 1 as an enhancer of Fas-mediated apoptosis of lung epithelial cells.J Immunol,2002,168:6470-6478.
10Thomas AQ,Lane K,Phillips J 3rd,et al.Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred.Am J Respir Crit Care Med,2002,165:1322-1328.
